Descriptor English: | Rifaximin | ||||||
Descriptor Spanish: |
Rifaximina
| ||||||
Descriptor Portuguese: | Rifaximina | ||||||
Descriptor French: | Rifaximine | ||||||
Entry term(s): |
4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin L 105 L-105 L105 Redactiv Xifaxan |
||||||
Tree number(s): |
D03.633.400.811.850 D04.345.295.750.850 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000078262 | ||||||
Scope note: | A synthetic rifamycin derivative and anti-bacterial agent that is used for the treatment of GASTROENTERITIS caused by ESCHERICHIA COLI INFECTIONS. It may also be used in the treatment of HEPATIC ENCEPHALOPATHY. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Bacterial Agents Gastrointestinal Agents |
||||||
Registry Number: | L36O5T016N | ||||||
CAS Type 1 Name: | 2,7-(Epoxy(1,11,13)pentadecatrienoimino)furo(2'',3'':7',8')naphth(1',2':4,5)imidazo(1,2-a)pyridine-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, ( 2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)- | ||||||
Public MeSH Note: | 2019; RIFAXIMIN was indexed under RIFAMYCINS 1983-2018 |
||||||
History Note: | 2019 (1983) |
||||||
DeCS ID: | 57794 | ||||||
Unique ID: | D000078262 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/05/21 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
Rifaximin
- Preferred
L 105
- Narrower
Redactiv
- Narrower
Xifaxan
- Narrower
Concept UI |
M0126046 |
Scope note | A synthetic rifamycin derivative and anti-bacterial agent that is used for the treatment of GASTROENTERITIS caused by ESCHERICHIA COLI INFECTIONS. It may also be used in the treatment of HEPATIC ENCEPHALOPATHY. |
Preferred term | Rifaximin |
Entry term(s) |
4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin |
Concept UI |
M0126044 |
Preferred term | L 105 |
Entry term(s) |
L-105 L105 |
Concept UI |
M0475049 |
Preferred term | Redactiv |
Concept UI |
M0492450 |
Preferred term | Xifaxan |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey